Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1134028

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Testicular Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how rates of testicular cancer diagnosis in the UK compare with ratse in other G20 countries over the last five years.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	268427
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>Age-adjusted rates within the G20 for testicular cancer vary from 0.6 to 10.1 per 100,000 over the last five years. The United Kingdom value is 7.1 per 100,000. There are differences in data recording across the world which will at least partly account for the range of values seen.</p><p>The estimated incidence of testicular cancer in the G20 group in 2018 is published by the International Agency for Research on Cancer Global Cancer Observatory project. This can be viewed at the following link:</p><p><a href="http://gco.iarc.fr/" target="_blank">http://gco.iarc.fr/</a></p><p>Data for the European Union, based on the EU 28 countries, is available at the European Cancer Information System at the following link:</p><p><a href="https://ecis.jrc.ec.europa.eu/" target="_blank">https://ecis.jrc.ec.europa.eu/</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 27/06/2019 15:19:33 answering member 4455 label Biography information for Seema Kennedy
tabling member	1409 label Biography information for Mr Gregory Campbell

1134030

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Preventive Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the NHS Diabetes Prevention Programme.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	268428
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>A first progress report covering early implementation of the programme, including numbers of referrals and uptake in its first year, was published as a short report in Diabetic Medicine and is available at the following link:</p><p><a href="https://onlinelibrary.wiley.com/doi/full/10.1111/dme.13562" target="_blank">https://onlinelibrary.wiley.com/doi/full/10.1111/dme.13562</a></p><p>The analyses show that referral numbers and percentage uptake are in excess of prior modelled values. Characteristics of attendees also suggest that the programme is reaching those who are both at greater risk of developing type 2 diabetes and who typically access healthcare less effectively.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 27/06/2019 15:22:24 answering member 4455 label Biography information for Seema Kennedy
tabling member	1409 label Biography information for Mr Gregory Campbell

1134036

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availablity of (a) critical and (b) short shelf-life medicines in the event of the UK leaving the EU without a deal.
tabling member constituency	Coatbridge, Chryston and Bellshill
tabling member printed	Hugh Gaffney
uin	268516
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>The Government fully understands that maintaining access to all medicines and medical products, including critical medicines and short shelf-life products, is vitally important to millions of people in this country. Ensuring unhindered supply of these products remains the Government’s top priority.</p><p> </p><p>As in preparation for 29 March and 12 April, our ‘no deal’ EU Exit contingency plans for 31 October will cover the NHS, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the Devolved Administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ EU Exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>In the case of medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes, we are working closely with suppliers to make alternative arrangements using airfreight.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a no-deal EU Exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 02/07/2019 11:33:39 answering member 1585 label Biography information for Stephen Hammond
tabling member	4614 label Biography information for Hugh Gaffney

1134074

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the continued smooth import and export of continence products and similar medical devices in the event of the UK leaving the EU without a deal; and if he will make a statement.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	268443
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>As in preparation for 29 March and 12 April, our contingency plans for 31 October will cover the National Health Service, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the devolved administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ European Union exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a ‘no deal’ EU exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 27/06/2019 15:10:41 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1134075

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what role has recently been played by Deloitte, and at what cost, in the development by NHS Improvement of proposals to introduce a centralised NHS procurement system for products and services; and what steps are being taken to ensure that the introduction of such a system does not lead to a restriction on the freedom of medical practitioners to prescribe any continence product on the Medicines Tariff that they consider to be the most appropriate product for the individual patient.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	268444
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>NHS Improvement, through an open and competitive procurement process, awarded Deloitte a contract to support NHS Improvement to develop a new NHS Procurement Target Operating Model. The contract for phase 1 of this work, which ended on 31 May 2019, cost £400,000.</p><p>The new Procurement Target Operating Model will consider the processes, data, and skills and capabilities to deliver a more efficient procurement service. The remit of the Procurement Target Operating Model programme does not cover clinical products and therefore were not considered as part of this review. NHS Improvement has collaborated with National Health Service providers’ chief executives, finance and procurement leads to develop the NHS’s procurement target operating model. Members of the Healthcare Supply Association have also been engaged with as part of the target operating model’s development.</p><p>Clinical products, including continence products, which are procured by the NHS are the remit of Supply Chain Coordination Limited who work with NHS providers’ procurement teams across England. Clinical product suppliers have not been engaged with on the new procurement target operating model as they are outside the its remit.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 268445 question first answered 02/07/2019 11:24:10 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1134076

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the (a) Health Care Supply Association, (b) main trade associations for suppliers of continence products and (c) organisations representing patients who use continence products have been consulted on the development by NHS Improvement of proposals to introduce a centralised NHS procurement system for products and services.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	268445
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>NHS Improvement, through an open and competitive procurement process, awarded Deloitte a contract to support NHS Improvement to develop a new NHS Procurement Target Operating Model. The contract for phase 1 of this work, which ended on 31 May 2019, cost £400,000.</p><p>The new Procurement Target Operating Model will consider the processes, data, and skills and capabilities to deliver a more efficient procurement service. The remit of the Procurement Target Operating Model programme does not cover clinical products and therefore were not considered as part of this review. NHS Improvement has collaborated with National Health Service providers’ chief executives, finance and procurement leads to develop the NHS’s procurement target operating model. Members of the Healthcare Supply Association have also been engaged with as part of the target operating model’s development.</p><p>Clinical products, including continence products, which are procured by the NHS are the remit of Supply Chain Coordination Limited who work with NHS providers’ procurement teams across England. Clinical product suppliers have not been engaged with on the new procurement target operating model as they are outside the its remit.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 268444 question first answered 02/07/2019 11:24:10 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1134077

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Preventive Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department will publish the Green Paper on prevention.
tabling member constituency	Brentford and Isleworth
tabling member printed	Ruth Cadbury
uin	268534
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>I refer the hon. Member to the answer given by the former Parliamentary Under-Secretary of State for Public Health and Primary Care (Steve Brine MP) to the hon. Member for Glasgow Central (Alison Thewliss MP) on 16 January 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-01-09/206879/" target="_blank">206879</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 27/06/2019 09:52:01 answering member 4455 label Biography information for Seema Kennedy
tabling member	4389 label Biography information for Ruth Cadbury

1134084

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to improve response times to recommendations for endovascular thrombectomy treatment for severe strokes which can be administered only within 24 hours.
tabling member constituency	Cynon Valley
tabling member printed	Ann Clwyd
uin	268413
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>In March 2018, NHS England published their policy document ‘Clinical Commissioning Policy Proposition: Mechanical thrombectomy for acute ischaemic stroke’ which outlines key recommendations for diagnosis, referral, and patient pathways for intervention, and treatment.</p><p>The document can be accessed at the following link:</p><p><a href="https://www.engage.england.nhs.uk/consultation/clinical-commissioning-consultation-may-2017/user_uploads/mechanical-thrombectomy-policy-proposition.pdf" target="_blank">https://www.engage.england.nhs.uk/consultation/clinical-commissioning-consultation-may-2017/user_uploads/mechanical-thrombectomy-policy-proposition.pdf</a></p><p>Stroke treatment outcomes are monitored by the Sentinel Stroke National Audit Programme against outcome measures for services which include:</p><p>- Time from onset to thrombectomy;</p><p>- Time from onset to arrival at thrombectomy centre;</p><p>- Time from arrival to arterial puncture; and</p><p>- Time from arterial puncture to thrombectomy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 02/07/2019 16:34:57 answering member 4455 label Biography information for Seema Kennedy
tabling member	553 label Biography information for Ann Clwyd

1134085

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has in place to increase the number of specialists trained in endovascular thrombectomy treatment.
tabling member constituency	Cynon Valley
tabling member printed	Ann Clwyd
uin	268414
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>In England, Health Education England (HEE) is supporting NHS England’s National Stroke Programme to support the education and training of the healthcare workforce in England to deliver stroke care, and this includes increasing the number of medical professionals able to carry out mechanical thrombectomy procedures. The interim NHS People Plan committed to the development of a credential for mechanical thrombectomy, to support the delivery of the NHS Long Term Plan. HEE will work with the Royal College of Radiologists who are developing a medical credential, and work is expected to be completed later in 2019. The Royal College of Radiologists’ remit is throughout the United Kingdom.</p><p>Staff numbers, education and training in Wales, Northern Ireland and Scotland is a matter for each of the devolved administrations in that country.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 02/07/2019 16:31:22 answering member 4455 label Biography information for Seema Kennedy
tabling member	553 label Biography information for Ann Clwyd

1134086

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason endovascular thrombectomy treatment is provided 24/7 only at Stoke-on-Trent hospital and St George's hospital in London; and what steps he plans to take to widen the provision of that service.
tabling member constituency	Cynon Valley
tabling member printed	Ann Clwyd
uin	268415
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>NHS England is responsible for commissioning endovascular thrombectomy treatment in designated specialised neuroscience centres.</p><p>Endovascular thrombectomy treatment requires specialist skills to maintain standards of safety and effectiveness. As the number of trained specialist doctors and staff who deliver the service is very small, not all health trusts provide these services.</p><p>Services are being developed nationally in 24 neuroscience centres, with 22 centres currently providing a thrombectomy service. These centres are extending their service hours in a phased and safe way while they recruit and train the required specialists.</p><p>Currently there are two centres providing a full 24/7 service, a further six centres will provide 24/7 services by the end of 2019/20. Other centres are developing their services and teams to extend their services over the coming years.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 268416 question first answered 02/07/2019 16:33:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	553 label Biography information for Ann Clwyd